What Highp Is (and why it’s different)
Highp is Direct-to-Phone Video Messaging. We deliver short, expert-led videos straight to HCPs’ phones—via secure links in SMS and compliant emails—removing the friction of portals and passwords. The result: instant access to content with embedded calls-to-action (sampling, webinar signup, rep call, materials) and full consent capture and analytics. Highp.me
Proof points from live pharma programs:
- Up to 30× better engagement than email
- ~99% mobile accessibility
- 40%+ video completion rates
All captured in-platform and ready for reporting.
Why Direct-to-Phone Video Wins in Pharma Marketing
- No logins, no passwords. HCPs tap → watch → act. That matters because authentication friction depresses digital engagement; industry leaders are investing to eliminate it. Highp removes the barrier from the outset. iqvia.com
- Video is the dominant digital format. Social and short-form video now anchor audience attention and ad spend—your branded scientific stories should ride that wave, not fight it. Deloitte Italia
- Clinician-validated content builds trust. Consumers engage weekly with health content and prefer clinician-reviewed information—another reason KOL-led video works. McKinsey & Company
How Highp Works
- Plan & produce: Turn slide decks into concise videos (KOL vlogs, product explainers, conference highlights, micro-learning serials).
- Target & consent: Use built-in consent capture, opt-out tracking, and customer data management—fully compliant.
- Deliver: Send secure, personalized video links direct to the phone via SMS and/or Approved Email.
- Engage & convert: One-tap CTAs to sample requests, rep callbacks, webinar registration, and more.
- Measure & optimize: Real-time analytics, segmentation, and reporting at HCP level.
Launch in days, not months—with over 20+ integrated tools replacing multiple vendors. Highp.me
Highp + Veeva: Better Results Without Custom IT
Highp amplifies Veeva CRM Approved Email: reps add a short, personalized video (recorded with an approved script) into the existing template via a simple link—no integration lift. In a DACH pilot, open rates doubled, 84% of emails were opened and 85% of videos watched; the program then scaled to additional BUs. Highp.me
Where Direct-to-Phone Video Fits Your Brand Plan
- Launch & LOE battlefields: Rapid SOV gains with expert-led explainers and HCP myth-busters.
- Conference highlights: Same-day “what matters” reels from ASH/ASCO/ESC delivered to phones.
- KOL serials (Netflix-style): Episodic micro-learning keeps clinicians returning, week after week.
- Field force enablement: Reps record short personal intros and follow-ups that drive next best actions.
- Medical & access comms: Clean consent trails, accurate audience definition, and verifiable reach.
All supported by global operations and transparent pricing (per sender and per delivered message).
KPIs to Expect (and Optimize Against)
- Engagement lift vs email: benchmark up to 30× better engagement.
- Completion rate: 40%+ finish videos when access is one-tap.
- Accessibility: ~99% via mobile delivery.
- Approved Email synergy: 2× open-rate improvement observed in Veeva pilots.
Marketing Data You Can Cite (Global Consulting Sources Only)
Use these datapoints to anchor your business case and MLR discussions:
- IQVIA (EMEA ChannelDynamics™ 2024): HCP channel preferences vary strongly by country and specialty; alignment with preferred mix is as low as 38–45% in the UK/DE, underscoring the need for precise, low-friction digital engagement. iqvia.com
- IQVIA (HCA, 2024): Repeated identity/consent prompts discourage HCPs; one-click “magic link” access markedly reduces friction—validating no-login engagement patterns. iqvia.com
- BCG (2025): Omnichannel programs delivered a 10× increase in HCP reach and a $200M value boost for a specialty pharma—evidence that orchestrated, data-driven touchpoints outperform siloed tactics. BCG
- Deloitte (2025): A majority of biopharma leaders say the commercial model must “change significantly or transform fully”; HCPs show content fatigue and skepticism toward pharma communications—making concise, high-value formats (e.g., short video) critical. Deloitte Italia
- McKinsey (2024): 75% of consumers engage with health & wellness content weekly and 77% find sponsored content helpful/neutral when well executed—supporting scaled, clinician-reviewed content plays. McKinsey & Company
- Deloitte Digital Media Trends (2025):
Why Highp for Your 2025 SOV Plan
- Built for pharma marketing: compliant consent, segmentation, analytics, and documentation.
- Designed for how HCPs engage today: one tap, on the phone, in the moment.
- Proven uplift: engagement, completion, and open-rate gains across launches and disease areas.
Next Steps
- Download Case Studies (Highp Casebook) to see formats, KPIs, and regulatory templates. Highp.me
- Explore Highp for Veeva Approved Email to double the impact of messages your field already sends. Highp.me
- Schedule a pilot: select one brand/indication, define HCP segments, and launch a 4–6-week direct-to-phone video program—optimize CTAs weekly and scale.
Contact.needtoreach
Contact.freeconsultation
Contact.consultationdescription